ArticleBMC medical informatics and decision making2025
A predictive model for the treatment outcomes of patients with secondary mitral regurgitation based on machine learning and model interpretation.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSecondary mitral regurgitation (SMR) is a common condition, with typical treatment options including conventional medical therapy and the latest transcatheter edge-to-edge repair. However, there is currently a lack of sufficient guidance on how to select the appropriate treatment approach for SMR patients. SMR is a common condition secondary to ischemic or non-ischemic heart failure, surgical or interventional therapy is preserved for those patients who showed no improvement after tailored guideline-directed medical therapy (GDMT) for heart failure.
objectiveOur goal is to develop an interpretable model to predict SMR improvement after medical treatment in the real-world, i.e. to find those patients who are candidates for surgical therapy. We employ the SHapley Additive exPlanations (SHAP) method to interpret the model and explore factors influencing improvement.
methodsIn this retrospective study, we extracted data on patients diagnosed with moderate or greater secondary mitral regurgitation. Predictive models were constructed, with the dataset randomly divided such that 80% was used for model training and 20% for model validation. We compared the predictive performance of the XGBoost model with three other machine learning models by analyzing the area under the curve (AUC). The XGBoost model was interpreted using the SHAP method, with variable importance assessed and the impact of key variables evaluated accordingly.
resultsThe study ultimately included 1,572 eligible SMR patients. The XGBoost model demonstrated the highest predictive performance among the four models, with an AUC of 0.73. The SHAP method identified and ranked the top 20 predictive factors for SMR, with age being the most significant predictor.
conclusionWe have developed an effective model to predict whether SMR patients will benefit from non-surgical treatment, which can help clinicians formulate better treatment plans and achieve optimal resource allocation. Additionally, the interpretable framework enhances the transparency of the model and helps doctors understand the reliability of the predictive model. CLINICAL
trial registrationClinical trial number: not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.